Publications Database

McDougle C. J. et al. (1997)

Risperidone treatment of children and adolescents with pervasive developmental disorders: A prospective, open-label study.

Journal of the American Academy of Child and Adolescent Psychiatry

36 pp. 685-693

Read Abstract (New Window)

Miral S. et al. (2008)

Risperidone versus haloperidol in children and adolescents with AD: a randomized, controlled, double-blind trial.

European Child and Adolescent Psychiatry

17(1), pp. 1-8.

Read Abstract (New Window)

Mukaddes N. M. , Abali O. , Gurkan K. (2004)

Short-term efficacy and safety of risperidone in young children with autistic disorder (AD).

World Journal of Bilogical Psychiatry

5(4), pp. 211-214

Read Abstract (New Window)

Myers S. M. , Johnson C. P. (2007)

Management of children with autism spectrum disorders.

Pediatrics

120(5), pp. 1162-1182

Read Abstract (New Window) Read Full (New Window)

Nickels K. et al. (2008)

Stimulant medication treatment of target behaviors in children with autism: a population-based study.

Journal of Developmental and Behavioral Pediatrics

29(2), pp. 75-81

Read Abstract (New Window) Read Full (New Window)

Oliver C. , Richards C. (2015)

Practitioner review: Self-injurious behaviour in children with developmental delay.

Journal of Child Psychology and Psychiatry

56(10), pp. 1042-1054.

Read Abstract (New Window)

Pearson D. A. et al. (2013)

Effects of extended release methylphenidate treatment on ratings of attention-deficit hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms.

Journal of Child and Adolescent Psychopharmacology

23(5), pp. 337-351.

Read Abstract (New Window) Read Full (New Window)

Research Units on Pediatric Psychopharmacology (RUPP) Autism Network (2005)

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.

Archives of General Psychiatry

Research Units on Pediatric Psychopharmacology (RUPP) Autism Network 62(11), pp. 1266-1274

Read Abstract (New Window) Read Full (New Window)

Richards C. et al. (2016)

Persistence of self-injurious behaviour in autism spectrum disorder over 3 years: a prospective cohort study of risk markers.

Journal of Neurodevelopmental Disorders

8, 21

Read Abstract (New Window) Read Full (New Window)

Richards C. et al. (2012)

Self-injurious behaviour in individuals with autism spectrum disorder and intellectual disability.

Journal of Intellectual Disability Research

56(5), pp. 476-489.

Read Abstract (New Window)

Richman D. M. et al. (2013)

Predictors of self-injurious behaviour exhibited by individuals with autism spectrum disorder.

Journal of Intellectual Disability Research

May, 57(5), pp. 429-430.

Read Abstract (New Window)

Rugino T. A. , Samsock T. C. (2002)

Levetiracetam in autistic children: an open-label study.

Journal of Developmental and Behavioral Pediatrics

23(4), pp. 225-230

Read Abstract (New Window)

Santosh P. J. et al. (2006)

Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.

Child: Care, Health and Development

32(5), pp. 575-583

Read Abstract (New Window)

Santosh P. J. , Baird G. (2001)

Pharmacotherapy of target symptoms in autistic spectrum disorders.

Indian Pediatrics

68(5), pp. 427-431

Read Abstract (New Window)

Self T. L. , Hale L. S. , Crumrine D. (2010)

Pharmacotherapy and children with autism spectrum disorder: A tutorial for speech-language pathologists.

Language, Speech, and Hearing Services in Schools

41 pp. 367-375.

Read Abstract (New Window)

Solomon L. , Peltz L. (2008)

Separation, autism, and residential treatment.

Journal of the Canadian Academy of Child and Adolescent Psychiatry

17(1), pp. 26-28

Read Full (New Window)

Sturm H. , Fernell E. , Gillberg C. (2004)

Autism spectrum disorders in children with normal intellectual levels: associated impairments and subgroups.

Developmental Medicine and Child Neurology

46(7), pp. 444-447

Read Abstract (New Window)

Sturman N. , Deckx L. , van Driel M. L. (2017)

Methylphenidate for children and adolescents with autism spectrum disorder.

Cochrane Database of Systematic Reviews

(11),

Read Abstract (New Window) Read Full (New Window)

Tuchman R. F. (2004)

AEDs and psychotropic drugs in children with autism and epilepsy.

Mental Retardation and Developmental Disabilities Research Reviews

10(2), pp. 135-138

Read Abstract (New Window)

Wasserman S. et al. (2006)

Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.

International Clinical Psychopharmacology

21(6), pp. 363-367

Read Abstract (New Window)